Remus Pharmaceuticals Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 63.50 | 45.03 | 24.72 | 18.42 | 11.92 |
| Operating profit | 20.04 | 10.55 | 4.07 | 0.76 | 0.39 |
| Interest | 0.32 | 0.23 | 0.09 | 0.04 | 0.04 |
| Gross profit | 23.42 | 11.89 | 4.70 | 1.53 | 1.20 |
| EPS (Rs) | 114.19 | 78.37 | 33.86 | 1025.80 | 811.60 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 3.69 | 1.58 | 0.72 | 0.81 | 0.85 |
| Stock adjustment | -1.38 | 1.30 | -0.44 | -0.71 | -0.40 |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 6.56 | 5.47 | 3.49 | 3.00 | 2.86 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 38.27 | 27.71 | 17.60 | 15.38 | 9.07 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.90 | 0.48 | 0.15 | 0.18 | 0.11 |
| Taxation | 5.71 | 2.91 | 1.16 | 0.33 | 0.28 |
| Net profit / loss | 16.82 | 8.50 | 3.39 | 1.03 | 0.81 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 1.47 | 1.09 | 1.00 | 0.01 | 0.01 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 31.57 | 23.42 | 16.47 | 4.14 | 3.29 |
| GPM (%) | 34.86 | 25.52 | 18.49 | 7.97 | 9.40 |
| NPM (%) | 25.03 | 18.24 | 13.31 | 5.34 | 6.36 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis